2011
Actinic Keratoses
Sponsor: Actavis Mid-Atlantic LLC
A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclaraâ„¢ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses
Phase: Phase Info Here
Start Date: February 2011
End Date: November 2011
Rosacea
Sponsor: Galderma Laboratories, L.P.
Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo
Phase: Phase 4
Start Date: April 2011
End Date: April 2012
Acne Vulgaris
Sponsor: Actavis Mid-Atlantic LLC
A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduoâ„¢ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of Mild to Severe Acne Vulgaris
Phase: Phase Info Here
Start Date: July 2011
End Date: December 2011
Papulopustular Rosacea (PPR)
Sponsor: Galderma
Phase 3 Papulopustular Rosacea Study
Phase: Phase 3
Start Date: December 2011
End Date: August 2013
Actinic Keratosis
Sponsor: DUSA Pharmaceuticals
Short-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK)
Phase: Phase 2
Start Date: December 2011
End Date: November 2012